The multiple myeloma landscape is evolving, with bispecific T-cell engagers offering hope.
Chloe Siu, PharmD, BCPS, BCOP
Advertisement
Articles by Chloe Siu, PharmD, BCPS, BCOP
This review discusses the prevalence, mechanisms of development, and evolving treatment landscape in chronic lymphocytic leukemia.
Advertisement
Latest Updated Articles
Emerging Bispecific T-Cell Engagers in Myeloma: Promises and HurdlesPublished: April 7th 2025 | Updated:
Pirtobrutinib and BTK Inhibitors in the CLL Treatment LandscapePublished: April 17th 2024 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
2
FDA Approves First Drug for Pediatrics With Irritable Bowel Syndrome With Constipation
3
Regular Melatonin Supplementation May Hide Hidden Heart Complications
4
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
5
